Literature DB >> 21982369

Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.

Laura A Volpicelli-Daley1, Kelvin C Luk, Tapan P Patel, Selcuk A Tanik, Dawn M Riddle, Anna Stieber, David F Meaney, John Q Trojanowski, Virginia M-Y Lee.   

Abstract

Inclusions composed of α-synuclein (α-syn), i.e., Lewy bodies (LBs) and Lewy neurites (LNs), define synucleinopathies including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Here, we demonstrate that preformed fibrils generated from full-length and truncated recombinant α-syn enter primary neurons, probably by adsorptive-mediated endocytosis, and promote recruitment of soluble endogenous α-syn into insoluble PD-like LBs and LNs. Remarkably, endogenous α-syn was sufficient for formation of these aggregates, and overexpression of wild-type or mutant α-syn was not required. LN-like pathology first developed in axons and propagated to form LB-like inclusions in perikarya. Accumulation of pathologic α-syn led to selective decreases in synaptic proteins, progressive impairments in neuronal excitability and connectivity, and, eventually, neuron death. Thus, our data contribute important insights into the etiology and pathogenesis of PD-like α-syn inclusions and their impact on neuronal functions, and they provide a model for discovering therapeutics targeting pathologic α-syn-mediated neurodegeneration.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982369      PMCID: PMC3204802          DOI: 10.1016/j.neuron.2011.08.033

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  43 in total

1.  Evidence for a partially folded intermediate in alpha-synuclein fibril formation.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

2.  A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

Authors:  B I Giasson; I V Murray; J Q Trojanowski; V M Lee
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

3.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

4.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

5.  Transcytotic pathway for blood-borne protein through the blood-brain barrier.

Authors:  R D Broadwell; B J Balin; M Salcman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

6.  The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation.

Authors:  Jeffrey C Kessler; Jean-Christophe Rochet; Peter T Lansbury
Journal:  Biochemistry       Date:  2003-01-28       Impact factor: 3.162

7.  Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.

Authors:  Ian V J Murray; Benoit I Giasson; Shawn M Quinn; Vishwanath Koppaka; Paul H Axelsen; Harry Ischiropoulos; John Q Trojanowski; Virginia M-Y Lee
Journal:  Biochemistry       Date:  2003-07-22       Impact factor: 3.162

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies.

Authors:  Deepak M Sampathu; Benoit I Giasson; Aaron C Pawlyk; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

10.  Detection of plasma membrane carbohydrates with lectin peroxidase conjugates.

Authors:  N K Gonatas; S Avrameas
Journal:  J Cell Biol       Date:  1973-11       Impact factor: 10.539

View more
  603 in total

Review 1.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 2.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

3.  Cell biology. A unifying role for prions in neurodegenerative diseases.

Authors:  Stanley B Prusiner
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

4.  Comparison of strategies for non-perturbing labeling of α-synuclein to study amyloidogenesis.

Authors:  Conor M Haney; Rebecca F Wissner; John B Warner; Yanxin J Wang; John J Ferrie; Dustin J Covell; Richard J Karpowicz; Virginia M-Y Lee; E James Petersson
Journal:  Org Biomol Chem       Date:  2016-02-07       Impact factor: 3.876

5.  The effect of truncation on prion-like properties of α-synuclein.

Authors:  Makoto Terada; Genjiro Suzuki; Takashi Nonaka; Fuyuki Kametani; Akira Tamaoka; Masato Hasegawa
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

6.  Exosomes-associated neurodegeneration and progression of Parkinson's disease.

Authors:  Isabella Russo; Luigi Bubacco; Elisa Greggio
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 7.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 8.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

9.  Synthetic polyubiquitinated α-Synuclein reveals important insights into the roles of the ubiquitin chain in regulating its pathophysiology.

Authors:  Mahmood Haj-Yahya; Bruno Fauvet; Yifat Herman-Bachinsky; Mirva Hejjaoui; Sudhir N Bavikar; Subramanian Vedhanarayanan Karthikeyan; Aaron Ciechanover; Hilal A Lashuel; Ashraf Brik
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

10.  Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells.

Authors:  Jianqun Gao; Gayathri Perera; Megha Bhadbhade; Glenda M Halliday; Nicolas Dzamko
Journal:  J Biol Chem       Date:  2019-08-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.